Heartstream Ventures into the Wilds of Public Access Defibrillation
Executive Summary
For someone suffering from sudden cardiac arrest, a quick response is the best medicine. But what if it comes form untrained people? Heartstream's AED device could save lives and advocates claim it should be more widely available--in airports, shopping malls, and all places of public gathering. But first the company has to deal with the challenge of making sure the device will be used properly. If they do, they may create the first consumer market for sophisticated medical equipment.
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.